X
(All Fields are required)
Media Coverage
''Need to Know: Medical Devices''
The PBS program "Need to Know" devoted a portion of their March 22 program to discuss medical devices.
They began by posing a question: is the federal government doing enough to protect our safety? Not from crime or terrorism but from the very real dangers of some medical devices cleared for use by the Food and Drug Administration. While the vast majority of these devices are safe and effective, the Government Accountability Office reports that hundreds are recalled every year. And the impact of an un-safe device? It can be devastating.
Joining host Jeff Greenfield on the program was Pew's Dr. Josh Rising, project director of the medical devices initiative at The Pew Charitable Trusts. Here is a portion of their conversation.
''JEFF GREENFIELD: Now I mentioned that you’re interested in regulation here and abroad. When you look abroad and look at other countries, how are they doing on the whole issue of regulation, medical safety, the safety of these medical devices, how do we stack up against some other first world countries?
DR. JOSH RISING: I think there’s one other very relevant example from Australia that I think would be illustrative to show the kind of potential of what can be done if you have a system that really tracks the medical devices. So in Australia they have what’s called a registry which tracks everybody in their country who’s gotten a hip or knee replacement. And this has been going on for about the past 10 or 12 years in Australia. And with this information, as they saw what happened with patients, they followed the patients over time, they discovered that patients who had metal on metal hip replacements, they discovered that patients had a much higher revision rate – meaning that the hip implants were having problems, and the surgeries need to be redone in these patients. And this was happening at a much higher rate than with patients who had other hip implants. So the registry communicated this information…and the docs in Australia stopped using these metal on metal hip replacements years before we stopped using them here in the United States. So it shows the potential that’s out there if we’re able to collect information on what’s happening in the real world with medical devices and what’s happening with medical devices and we can take appropriate action when we find if there are some devices that do have some problems.
...
JEFF GREENFIELD: We've heard from some companies that you put on more regulation, what you're going to do is you’re going to increase cost, you’re going to slow innovation. Is that relevant to what you’ve been talking about in terms of what you want to see done? Is that a legitimate concern?
DR. JOSH RISING: You know certainly we think of a better system of post market surveillance of figuring out what’s happening in the real world as being a win for both safety and innovation.
You know there’s some people who talk about safety and innovation as being diametrically opposed that if you improve safety, you’re going to hurt innovation or vice versa. But we see post market surveillance as a way where you can really achieve the best of both worlds. And that’s if we’re able to collect real time information on what’s happening with medical devices we can improve safety because we can identify devices that might be problematic and then remove them from the market place, but it’s also going to help innovation because this is also going to give manufacturers much more information about what’s happening with their devices than they have now, and they’re going to be able to use that information in the next generation of their devices, so we really see this need to collect more information on these devices as being both a win in the safety and innovation columns.''
The Pew Charitable Trusts and the Premier healthcare alliance sent the White House Office of Management and Budget a letter regarding the review of a Food and Drug Administration rule to establish a unique device identifier (UDI) system. Given the importance of this new device identification system to improve patient care and the missed statutory deadline, in this correspondence Josh Rising of Pew and Blair Childs of Premier strongly urged the Director of the Office of Management and Budget (OMB) to promptly complete review of the UDI final rule.
More info
A letter from Josh Rising — director of Pew's Medical Device Initiative — to The White House Office of Management and Budget, requesting a speedy review of regulations to develop a unique device identifier (UDI) system.
More info
'You may not yet depend on a pacemaker, defibrillator, stent, joint implant or any of the other life-changing, potentially lifesaving products made by the medical device industry. But chances are you or a family member will be a patient some day. That’s why it isn’t just the medical device industry that has a stake in the timely rollout of a long-overdue national system to better track the safety and whereabouts of devices once they’re on the market or in use."
More info
A letter from Josh Rising, director of Pew's Medical Device Initiative, about updates on the unique device identifier system.
More info
FDA recently updated the national medical device postmarket surveillance plan – listing device identification and registries as the cornerstones for effective product monitoring. In this letter, medical devices director Josh Rising applauds the agency for making unique device identifiers and registries central to this plan.
More info
The U.S. Food and Drug Administration (FDA) has issued a proposed rule that would require manufacturers of medical devices, with certain exceptions, to place a unique identifier on the label of medical devices. Some medical devices would also need to be directly marked with the unique identifier.
More info
The three co-chairs of the New Democrat Health Care task Force – Reps. Allyson Schwartz, Kurt Schrader and Bill Owens – sent FDA a letter inquiring about the status of the agency’s final regulations to establish a unique device identifier (UDI) system and database.
More info
The Pew Charitable Trusts submitted comments on preliminary recommendations regarding Stage 3 meaningful use objectives and standards for electronic health records (EHRs) to the Office of the National Coordinator for Health Information Technology. These comments follow remarks at recent meetings of the Health Information Technology (HIT) Policy Committee and HIT Standards Committee.
More info
This year's celebration of National Public Health Week (NPHW) focuses on the theme, "Public Health is ROI: Save Lives, Save Money." Join us in recognizing the work of Pew's Health Initiatives.
More info
The U.S. Food and Drug Administration announced last month that it will classify metal-on-metal hip implants as high-risk devices. That comes after the artificial joints were found to have failed at high rates, causing disability and meaning additional surgery for thousands of people. But hundreds of other potentially high-risk medical devices remain in use without what many consider to be adequate testing
More info
On Feb. 1, 2013, the Centers for Medicare & Medicaid Services published the final rule guiding implementation of the Physician Payments Sunshine Act, which Congress passed as part of the Affordable Care Act in March 2010 to increase transparency in the relationships between physicians and drug and medical device makers. Here are some of the highlights.
More info
In comments to the Office of the National Coordinator for Health Information Technology (ONC), the American College of Cardiology, Consumers Union, the National Women's Health Network, the National Research Center for Women and Families, the Trust for America's Health, and The Pew Charitable Trusts urge the ONC to promote adoption of the unique device identification (UDI) system for medical devices to improve the safety of medical care.
More info
"After 15 months of delay, the Centers for Medicare & Medicaid Services has finally released the long-awaited Sunshine Act rule, which establishes procedures for gathering and publishing data containing financial ties between physicians, teaching hospitals and drug and device makers, as well as group purchasing organizations."
More info
In comments to the Office of the National Coordinator for Health Information Technology (ONC), the American College of Cardiology and The Pew Charitable Trusts urge the ONC to incorporate medical device identifiers developed under the FDA’s unique device identification (UDI) system into both electronic health record (EHR) certification criteria and Stage 3 meaningful use (MU) objectives.
More info
''Drug and medical-device makers are bracing for a new U.S. rule that will require them to report physician-payment information to the government--a rule some companies and doctors fear will be overly broad and could mislead the public.''
More info